Sort
39,280 grants matching “leukemia”
Structural Biology of AML (CBFA2) and AML1-ETO
$355,855John Hackett Bushweller · University Of Virginia · R01 · FY2011 · CA
Targeting Cancer Stem Cells
$355,855Richard J Jones · Johns Hopkins University · P01 · FY2009 · CA
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
$355,854Christopher Y Park · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Role of IDH Mutations in Acute Myeloid Malignancies
$355,854Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Structural Biology of AML (CBFA2) and AML1-ETO
$355,853John Hackett Bushweller · University Of Virginia · R01 · FY2012 · CA
Project 3: Targeted therapy for splicing factor mutant myeloid malignancies
$355,822Matthew J Walter · Washington University · P50 · FY2024 · CA
Cord Blood T Cell Therapy for Myeloid Malignancies
$355,822Jeffrey J Molldrem · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
CD38 Pretargeted Radioimmunotherapy for Myeloma
$355,791Oliver W. Press · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
CD38 Pretargeted Radioimmunotherapy for Myeloma
$355,791Damian J. Green · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$355,756Neil Osheroff · Vanderbilt University · R01 · FY2022 · GM
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$355,756Neil Osheroff · Vanderbilt University · R01 · FY2025 · GM
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$355,756Neil Osheroff · Vanderbilt University · R01 · FY2024 · GM
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$355,756Neil Osheroff · Vanderbilt University · R01 · FY2023 · GM
Cord Blood T Cell Therapy for Myeloid Malignancies
$355,740Jeffrey J Molldrem · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
GPCR - Linked RhoGEFs in Tumor Growth and Metastasis
$355,725John J G Tesmer · Purdue University · R01 · FY2021 · CA
GPCR - Linked RhoGEFs in Tumor Growth and Metastasis
$355,725John J G Tesmer · Purdue University · R01 · FY2020 · CA
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
$355,711Kira Gritsman · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA
Microenvironment-induced metabolic plasticity in leukemia stem cells
$355,706Craig T. Jordan · University Of Colorado Denver · R01 · FY2020 · CA
Dysregulated genome architecture in acute myeloid leukemia
$355,706David H Spencer · Washington University · R37 · FY2025 · CA
Microenvironment-induced metabolic plasticity in leukemia stem cells
$355,706Craig T. Jordan · University Of Colorado Denver · R01 · FY2018 · CA
Decoding 41BB-specific dysfunction programs in cellular immunotherapies for cancer
$355,706Nathan Singh · Washington University · R37 · FY2025 · CA
Decoding 41BB-specific dysfunction programs in cellular immunotherapies for cancer
$355,706Nathan Singh · Washington University · R37 · FY2024 · CA
Molecular pathogenesis of MLL-AF4 leukemias
$355,690Scott A Armstrong · Boston Children'S Hospital · R01 · FY2010 · CA
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia
$355,665Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2022 · DK
Southwest Oncology Group
$355,660Loyola University Chicago · U10 · FY2004 · CA